Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CNCE
FechaHoraFuenteTítuloSímboloCompañía
29/10/202006:00Business WireConcert Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020NASDAQ:CNCEConcert Pharmaceuticals Inc
22/10/202006:00Business WireConcert Pharmaceuticals Announces Publication on Alopecia Areata Burden of Disease in Journal of Investigative DermatologyNASDAQ:CNCEConcert Pharmaceuticals Inc
13/10/202006:00Business WireConcert Pharmaceuticals Announces CTP-543 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2020 EADV Virtu...NASDAQ:CNCEConcert Pharmaceuticals Inc
29/09/202006:00Business WireConcert Pharmaceuticals Completes Enrollment in CTP-692 Phase 2 Trial in Patients with SchizophreniaNASDAQ:CNCEConcert Pharmaceuticals Inc
08/09/202006:00Business WireConcert Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:CNCEConcert Pharmaceuticals Inc
01/09/202015:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
18/08/202005:00Business WireConcert Pharmaceuticals to Present at The JMP Securities CNS ForumNASDAQ:CNCEConcert Pharmaceuticals Inc
06/08/202006:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/08/202006:00Business WireConcert Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Company UpdateNASDAQ:CNCEConcert Pharmaceuticals Inc
30/07/202006:00Business WireConcert Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 6, 2020NASDAQ:CNCEConcert Pharmaceuticals Inc
12/06/202015:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
12/06/202015:01Business WireConcert Pharmaceuticals Releases Additional Data from Phase 2 Clinical Trial of CTP-543 in Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
26/05/202006:00Business WireConcert Pharmaceuticals to Webcast Fireside Chat at Jefferies Virtual Global Healthcare ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
12/05/202006:00Business WireConcert Pharmaceuticals to Webcast Presentation at UBS Virtual Healthcare ConferenceNASDAQ:CNCEConcert Pharmaceuticals Inc
30/04/202006:00Business WireConcert Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Update on Clinical ProgramsNASDAQ:CNCEConcert Pharmaceuticals Inc
28/04/202006:33Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CNCEConcert Pharmaceuticals Inc
28/04/202006:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CNCEConcert Pharmaceuticals Inc
23/04/202006:00Business WireConcert Pharmaceuticals to Report First Quarter 2020 Financial Results on April 30, 2020NASDAQ:CNCEConcert Pharmaceuticals Inc
01/04/202006:00Business WireConcert Pharmaceuticals Announces Plans for CTP-543 Phase 3 Trials in Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
27/02/202006:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNCEConcert Pharmaceuticals Inc
27/02/202006:25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
27/02/202006:00Business WireConcert Pharmaceuticals Reports 2019 Financial Results and Provides Update on Clinical ProgramsNASDAQ:CNCEConcert Pharmaceuticals Inc
24/02/202006:00Business WireConcert Pharmaceuticals Selected for Late-Breaking Oral Presentation of CTP-543 Phase 2 Data in Alopecia Areata at the 2020 A...NASDAQ:CNCEConcert Pharmaceuticals Inc
20/02/202006:00Business WireConcert Pharmaceuticals to Report Full Year 2019 Results on February 27, 2020NASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202000:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202012:00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
30/01/202015:01Business WireConcert Pharmaceuticals Announces Closing of Public Offering & Full Exercise of Underwriters’ Option to Purchase Additional...NASDAQ:CNCEConcert Pharmaceuticals Inc
28/01/202015:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CNCEConcert Pharmaceuticals Inc
28/01/202008:00Business WireConcert Pharmaceuticals Announces Pricing of Public OfferingNASDAQ:CNCEConcert Pharmaceuticals Inc
27/01/202015:02Business WireConcert Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE

Su Consulta Reciente

Delayed Upgrade Clock